Panel, Conference Presentation
Will You Live to a Healthy 100?
- The session aims to expand health span—the period of life free from aging-related illnesses—by shifting focus from treating specific diseases like arthritis and renal failure to improving functional components such as hearing, balance, and memory.
- Companies are expected to transition their longevity strategies toward removing senescent cells via non-genetic drug interventions to mitigate negative effects on healthy neighbors.
- Current research on extending animal lifespans, particularly in mice, offers reliable guideposts for human intervention, aiming to yield results well before waiting 80 to 100 years for traditional longevity data.
- A placebo-controlled trial involving rapamycin in dogs is anticipated to provide evidence regarding lifespan extension within a few years.
- Metformin is projected to delay diabetes by 30% in non-diabetic individuals, reduce cardiovascular disease by 30% in diabetics, and lower cancer rates by 30% across all types.
- The Targeting Aging with Metformin (TAME) study plans to enroll 3,000 participants aged 65 to 80 to determine if metformin delays a composite endpoint of cardiovascular disease, cancer, Alzheimer's, or mortality.
- The TAME study expects to gather sufficient data to demonstrate an aging delay within four to five years, potentially resulting in a two-year extension of health span.
- Final funding review for the TAME trial, potentially co-funded by the American Federation of Aging Research and NIH, is scheduled for June 16, with study initiation expected at the end of summer if approved.
- A conservative assessment suggests that extending health span by two years could generate a longevity dividend of $7 trillion by 2050.
- Precision longevity, which utilizes biomarkers to predict specific diseases and tailor interventions like metformin or rapamycin, is identified as the future trajectory for the field.
- The National Academy of Medicine is convening a committee to define criteria and solicit ideas for an Aging and Longevity Grand Challenge prize.
- The concept of living 80 years while maintaining a biological age of 60 is characterized as an active scientific pursuit rather than science fiction.